Form 424B5 SAB Biotherapeutics,

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. TSLA
4. CME
5. USO
6. AMD
7. EVTL
8. ATH
9. SPY
10. KLC

Go back to Form 424B5 SAB Biotherapeutics,

SAB Biotherapeutics (SABS) Enters $20M Equity Sales Agreement

January 26, 2024 4:05 PM EST

SAB Biotherapeutics (NASDAQ: SABS) entered into a Controlled Equity Offering Sales Agreement (the Sales Agreement) with Cantor Fitzgerald & Co. (Cantor or the sales agent), relating to shares of our common stock, par value $0.0001 per share, offered by this prospectus supplement. In accordance with the terms of the... More